Symbol="PSTV"
AssetType="Common Stock"
Name="Plus Therapeutics Inc"
Description="Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing, and commercialization of treatments for patients with cancer and other diseases. The company is headquartered in Austin, Texas."
CIK="1095981"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SURGICAL & MEDICAL INSTRUMENTS & APPARATUS"
Address="4200 MARATHON BLVD., SUITE 200, AUSTIN, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="6709500"
EBITDA="-16241000"
PERatio="None"
PEGRatio="None"
BookValue="0.924"
DividendPerShare="0"
DividendYield="0"
EPS="-7.96"
RevenuePerShareTTM="1.16"
ProfitMargin="0"
OperatingMarginTTM="-6.53"
ReturnOnAssetsTTM="-0.595"
ReturnOnEquityTTM="-2.782"
RevenueTTM="2584000"
GrossProfitTTM="-9474000"
DilutedEPSTTM="-7.96"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="20.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="143.61"
PriceToBookRatio="1.031"
EVToRevenue="102.73"
EVToEBITDA="0.144"
Beta="0.343"
num_52WeekHigh="15.45"
num_52WeekLow="1.97"
num_50DayMovingAverage="2.496"
num_200DayMovingAverage="4.417"
SharesOutstanding="2879600"
DividendDate="2019-08-06"
ExDividendDate="None"
symbol="PSTV"
open="2.31"
high="2.41"
low="2.31"
price="2.38"
volume="5319.00"
latest_trading_day="2023-08-23"
previous_close="2.33"
change="0.05"
change_percent="2.1459%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="109418"
Change_recent_avg="-0.03"
Delta_recent_avg="0.22"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-1.56"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_negative_thumbnail_id_2="127"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0049.jpeg"
image_neutral_thumbnail_id_1="521"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_neutral_thumbnail_id_2="526"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_positive_thumbnail_id_1="648"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0060.jpeg"
image_positive_thumbnail_id_2="670"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0038.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
